Roles of the Transcription Factors Snail and Slug During Mammary Morphogenesis and Breast Carcinoma Progression (original) (raw)

REFERENCES

1. Smith D, Franco del Amo F, Gridley T. Isolation of Sna, amouse gene homologous to the Drosophila genes snail and escargot: its expression pattern suggests multiple roles during postimplantation development. Development 1992 Dec;116(4):1033-9. Erratum in: Development 1993 Mar;117(3):precedi 1992.
   PubMed Google Scholar
2. Hemavathy K, Ashraf S, Ip Y. Snail/slug family of repressors: slowly going into the fast lane of development and cancer. Genetics 2000;257:1-12.
   Google Scholar
3. Nieto MA, Sargent MG, Wilkinson DG, Cooke J. Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science 1994;264:835-9.
   PubMed Google Scholar
4. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002;3:155-66.
   PubMed Google Scholar
5. Nibu Y, Zhang H, Bajor E, Barolo S, Small S, Levine M. dCtBP mediates transcriptional repression by Knirps, Kruppel and Snail in the Drosophila embryo. EMBO J. 1998;17:7009-20.
   PubMed Google Scholar
6. Savagner P. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 2001;23:912-23.
   PubMed Google Scholar
7. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nature Rev 2002;2:442-54.
   Google Scholar
8. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000;2:76-83.
   PubMed Google Scholar
9. Batlle E, Sancho E, Franci C, DominguezD, Monfar M, Baulida J, et al. The transcription factor snail is a repressor of Ecadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000;2:84-9.
   PubMed Google Scholar
10. Poser I, DominguezD, de Herreros AG, Varnai A, Buettner R, Bosserhoff AK. Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail. J Biol Chem 2001;276:24661-6.
    PubMed Google Scholar
11. Yokoyama K, Kamata N, Hayashi E, Hoteiya T, Ueda N, Fujimoto R, et al. Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol 2001;37:65-71.
    PubMed Google Scholar
12. Jiao W, Miyazaki K, Kitajima Y. Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. Br J Cancer 2002;86:98-101.
    PubMed Google Scholar
13. Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002;62:1613-8.
    PubMed Google Scholar
14. Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 2003;116:499-511.
    PubMed Google Scholar
15. Chen S, Itoh T, Wu K, Zhou D, Yang C. Transcriptional regulation of aromatase expression in human breast tissue. J Steroid Biochem Mol Biol 2002;83:93-9.
    PubMed Google Scholar
16. Seki K, Fujimori T, Savagner P, Hata A, Aikawa T, Ogata N, et al.MouseSnail family transcription repressors regulate chondrocyte extracellular matrix, type II collagen and aggrecan. J Biol Chem 2003.
17. Espineda CE, Chang J, Twiss J, Rajasekaran SA, Rajasekaran AK. Repression of Na,K-ATPase ta1-subunit by the transcription factor Snail in carcinoma. Mol Biol Cell 2003.
18. Ikenouchi J, Matsuda M, Furuse M, Tsukita S. Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci. 2003;116:1959-67.
    PubMed Google Scholar
19. Peinado H, Ballestar E, Esteller M, Cano A. Snail mediates Ecadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol 2004;24:306-19.
    PubMed Google Scholar
20. Carver EA, Jiang R, Lan Y, Oram KF, Gridley T. The mouse snail gene encodes a key regulator of the epithelialmesenchymal transition. Mol Cell Biol 2001;21:8184-8.
    PubMed Google Scholar
21. Jiang R, Lan Y, Norton C, Sundberg J, Gridley T. The Slug gene is not essential for mesoderm or neural crest development in mice. Dev Biol 1998;198:277-85.
    PubMed Google Scholar
22. Savagner P, Karavanova I, Perantoni A, Thiery JP, Yamada KM. Slug mRNA is expressed by specific mesodermal derivatives during rodent organogenesis. Dev Dyn 1998;213:182-7.
    PubMed Google Scholar
23. Cheng CW, Wu PE, Yu JC, Huang CS, Yue CT, Wu CW, et al. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 2001;20:3814-23.
    PubMed Google Scholar
24. Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J, et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 2002;21:3241-6.
    PubMed Google Scholar
25. Kowalski PJ, Rubin MA, Kleer CG. E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 2003;5:R217-22. Epub 2003 Sep 26.
    PubMed Google Scholar
26. Demir A, Groothuis P, Nap A, Punyadeera C, de Goei A, Evers J, et al. Menstrual effluent induces epithelial-mesenchymal transitions in mesothelial cells. Hum Reprod 2004;19:21-9.
    PubMed Google Scholar
27. Inoue A, Seidel M, Wu W, Kamizono S, Ferrando A, Bronson R, et al. Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiationinduced apoptosis in vivo. Cancer Cell 2002;2:279-88.
    PubMed Google Scholar
28. Okubo T, Truong TK, Yu B, Itoh T, Zhao J, Grube B, et al. Down-regulation of promoter 1.3 activity of the human aromatase gene in breast tissue by zinc-finger protein, snail (SnaH). Cancer Res 2001;15:1338-46.
    Google Scholar
29. Perez-Losada J, Sanchez-Martin M, Perez-Caro M, Perez-Mancera PA, Sanchez-Garcia I. The radioresistance biological function of the SCF/kit signaling pathway is mediated by the zinc-finger transcription factor Slug. Oncogene 2003;22:4205-11.
    PubMed Google Scholar
30. Perez-Losada J, Sanchez-Martin M, Rodriguez-Garcia A, Sanchez ML, Orfao A, Flores T, et al. Zinc-finger transcription factor Slug contributes to the function of the stem cell factor c-kit signaling pathway. Blood 2002;100:1274-86.
    PubMed Google Scholar
31. Li ML, Aggeler J, Farson DA, Hatier C, Hassell J, Bissell MJ. Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells. Proc Natl Acad Sci U S A 1987;84:136-40.
    PubMed Google Scholar
32. Petersen QW, Ronnov-Jessen L, Howlett AR, Bissel M. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Nat Acad Sci U. S. A. 1992;89:9064-8.
    Google Scholar
33. Thompson EW, Torri J, Sabol M, Sommers CL, Byers S, Valverius EM, et al. Oncogene-induced basement membrane invasiveness in human mammary epithelial cells. Clin Exp Metastasis 1994;12:181-94.
    PubMed Google Scholar
34. Larue LOM, Hirchenhain J, Kemler R. E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc Natl Acad Sci U S A 1994;91:8263-7.
    PubMed Google Scholar
35. BerxG, Van Roy F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 2001;3:289-93.
    PubMed Google Scholar
36. Hunt NC, Douglas-Jones AG, Jasani B, Morgan JM, Pignatelli M. Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Archiv 1997;430:285-9.
    PubMed Google Scholar
37. Asgeirsson KS, Jónasson JG, Tryggvadóttir L, Ólafsdóttir K, Sigurgeirsdóttir JR, Ingvarsson S, et al. Altered expression of E-cadherin in breast cancer. patterns, mechanisms and clinical significance. Eur J Cancer 2000;36:1098-106.
    PubMed Google Scholar
38. Gupta SK, Douglas-Jones AG, Jasani B, Morgan JM, Pignatelli M, Mansel RE. E-cadherin (E-cad) expression in duct carcinoma in situ (DCIS) of the breast. Virchows Arch 1997;430:23-8.
    PubMed Google Scholar
39. Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M, et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993;142:987-93.
    PubMed Google Scholar
40. Parker C, Rampaul RS, Pinder SE, Bell JA, Wencyk PM, Blamey RW, et al. E-cadherin as a prognostic indicator in primary breast cancer. Br J Cancer 2001;85:1958-63.
    PubMed Google Scholar
41. Lipponen P, Saarelainen E, Ji H, Aaltomaa S, Syrjanen K. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol 1994;174:101-9.
    PubMed Google Scholar
42. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993;53:1696-701.
    PubMed Google Scholar
43. Daniel CW, Strickland P, Friedmann Y. Expression and functional role of E-and P-cadherin in mouse mammary ductal morphogenesis and growth. Dev Biol 1995;169:511-9.
    PubMed Google Scholar
44. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. Acausal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998;392:190-3.
    PubMed Google Scholar
45. Reis-Filho JS, Cancela Paredes J, Milanezi F, Schmitt FC. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast. Cancer 2002;94:2114-5; discussion 5-6.
    PubMed Google Scholar
46. Kanai Y, Oda T, Tsuda H, Ochiai A, Hirohashi S.Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Jpn J Cancer Res 1994;85:1035-9.
    PubMed Google Scholar
47. Huiping C, Sigurgeirsdottir JR, Jonasson JG, Eiriksdottir G, Johannsdottir JT, Egilsson V, et al. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer. Br J Cancer 1999;81:1103-10.
    PubMed Google Scholar
48. Lei H, Sjoberg-Margolin S, Salahshor S, Werelius B, Jandakova E, Hemminki K, et al. CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk. Int J Cancer 2002;98:199-204.
    PubMed Google Scholar
49. Berx G, Cleton-Jansen AM, Strumane K, de Leeuw WJ, Nollet F, van Roy F, et al. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 1996;13:1919-25.
    PubMed Google Scholar
50. Bukholm IK, Nesland JM, Borresen-Dale AL. Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [see comments]. J Pathol 2000;190:15-9.
    PubMed Google Scholar
51. Nas SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, Davidson NE, et al. Aberrant methylation of the estrogen Roles of Snail Genes During Mammary Morphogenesis and Cancer 193 receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer. Cancer Res 2000;60:4346-8.
    PubMed Google Scholar
52. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 1995;55:5195-9.
    PubMed Google Scholar
53. Hennig G, Lowrick O, Birchmeier W, Behrens J. Mechanisms identified in the transcriptional control of epithelial gene expression. J Biol Chem 1996;271:595-602.
    PubMed Google Scholar
54. Batsche E, Muchardt C, Behrens J, Hurst HC, Cremisi C. RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol Cell Biol 1998;18:3647-58.
    PubMed Google Scholar
55. Miettinen PJ, Ebner R, Lopez AR, Derynck R. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 1994;127:2021-36.
    PubMed Google Scholar
56. Hosono S, Gross I, English MA, Hajra KM, Fearon ER, Licht JD. E-cadherin is a WT1 target gene. J Biol Chem 2000;275:10943-53.
    PubMed Google Scholar
57. Tan C, Costello P, Sanghera J, Dominguez D, Baulida J, de Herreros AG, et al. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/-human colon carcinoma cells. Oncogene 2001;20:133-40.
    PubMed Google Scholar
58. D'Souza B, Taylor-Papadimitriou J. Overexpression of erb-B2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene. Proc Natl Acad Sci USA 1994;91:7202-6.
    PubMed Google Scholar
59. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion.Mol Cell 2001;7:1267-78.
    PubMed Google Scholar
60. Yokoyama K, Kamata N, Fujimoto R, Tsutsumi S, Tomonari M, Taki M, et al. Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas. Int J Oncol 2003;22:891-8.
    PubMed Google Scholar
61. Prall OW RE, Sutherland RL. Estrogen regulation of cell cycle progression in breast cancer cells. J Steroid Biochem Mol Biol 1998;65:169-74.
    PubMed Google Scholar
62. Masood S. Immunocytochemical localization of estrogen and progesterone receptors in imprint preparations of breast carcinomas. Cancer Cell 1992;70:2109-14.
    Google Scholar
63. Chen S, Zhou D, Yang C, Okubo T, Kinoshita Y, Yu B, et al. Modulation of aromatase expression in human breast tissue. J Steroid Biochem Mol Biol 2001;79:35-40.
    PubMed Google Scholar
64. James VH, McNeill JM, Lai LC, Newton CJ, Ghilchik MW, Reed MJ. Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies. Steroids 1987;50: 269-79.
    PubMed Google Scholar
65. Chen S, Zhou D, Okubo T, Kao Y, Eng E, Grube B, et al. Prevention and treatment of breast cancer by suppressing aromatase activity and expression. Ann N Y Acad Sci 2002;963:229-38.
    PubMed Google Scholar
66. Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, Wade PA. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 2003;113: 207-19.
    PubMed Google Scholar
67. Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995;19:183-232.
    PubMed Google Scholar
68. Boyer B, Roche S, Denoyelle M, Thiery JP. Src and Ras are involved in separate pathways in epithelial cell scattering. Embo Journal 1997;16:5904-13.
    PubMed Google Scholar
69. Lu Z, Ghosh S, Wang Z, Hunter T. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 2003;4:499-515.
    PubMed Google Scholar
70. Schmidt-Ullrich RK, Mikkelsen RB, Dent P, Todd DG, Valerie K, Kavanagh BD, et al. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent onEGFR tyrosine phosphorylation. Oncogene 1997;15:1191-7.
    PubMed Google Scholar
71. Hines SJ, Organ C, Kornstein MJ, Krystal GW. Coexpression of the c-kit and stem cell factor genes in breast carcinomas. Cell Growth Differ 1995;6:769-79.
    PubMed Google Scholar

Download references